Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".

Kazi, Dhruv S, Brandon K Bellows, John A Spertus, Suzanne J Baron, Changyu Shen, David J Cohen, Robert W Yeh, et al. 2020. “Response by Kazi et Al to Letter Regarding Article, ‘Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy’.”. Circulation 142 (15): e212-e213.